You are viewing an incomplete version of our website. Please click to reload the website as full version.

Suppression of Tumorigenicity 14 (Colon Carcinoma) Proteins (ST14)

The protein encoded by ST14 is an epithelial-derived, integral membrane serine protease. Additionally we are shipping Suppression of Tumorigenicity 14 (Colon Carcinoma) Antibodies (91) and Suppression of Tumorigenicity 14 (Colon Carcinoma) Kits (6) and many more products for this protein.

list all proteins Gene Name GeneID UniProt
ST14 6768 Q9Y5Y6
ST14 19143 P56677
Rat ST14 ST14 114093  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top Suppression of Tumorigenicity 14 (Colon Carcinoma) Proteins at antibodies-online.com

Showing 6 out of 7 products:

Catalog No. Origin Source Conjugate Images Quantity Supplier Delivery Price Details
Insect Cells Mouse rho-1D4 tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 0.25 mg Log in to see 59 to 64 Days
$6,052.17
Details
Insect Cells Human rho-1D4 tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 0.5 mg Log in to see 59 to 64 Days
$8,623.45
Details
HOST_Escherichia coli (E. coli) Mouse His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Log in to see 39 to 44 Days
$9,248.02
Details
HOST_Escherichia coli (E. coli) Human His tag „Crystallography Grade“ protein due to multi-step, protein-specific purification process 1 mg Log in to see 39 to 44 Days
$9,248.02
Details
HOST_Wheat germ Human GST tag 10 μg Log in to see 9 Days
$405.71
Details
HOST_Escherichia coli (E. coli) Human His tag   100 μg Log in to see 11 to 13 Days
$668.80
Details

ST14 Proteins by Origin and Source

Origin Expressed in Conjugate
Human , ,
, ,
Mouse (Murine) ,
,

More Proteins for Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) Interaction Partners

Human Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) interaction partners

  1. Given that matriptase-1 participates in terminal KC differentiation, its absence in psoriatic skin lesions indicates that this contributes to the barrier disturbances in this disease.

  2. Novel findings reveal a new paradigm in matriptase activation involving PDGF-D (show PDGFD Proteins)-specific signal transduction leading to extracellular acidosis.

  3. Maritriptase is required for pro-HGF/c-Met signaling and cell proliferation in breast cancer cells.

  4. Matriptase inhibition by HAI-2 (show SPINT2 Proteins) requires the translocation of HAI-2 (show SPINT2 Proteins) to the cell surface, a process which is observed in some breast cancer cells but not in mammary epithelial cells.

  5. prostate cancer cell invasion is stimulated by a rapid but sustained increase in Src (show SRC Proteins) activity, mediated non-genomically by cytoplasmic AR, leading to rapid activation and shedding of the laminin protease Matriptase

  6. Report potent/specific inhibition of matriptase by the cyclic microprotein MCoTI-II.

  7. Matriptase expression correlates with tumour progression and invasive capability in oral squamous cell carcinoma

  8. Matriptase can act as a cellular sensor of the chemical environment of the cell that allows the cell to respond to and protect itself from changes in the chemical milieu.

  9. It presents evidence that matriptase efficiently cleaves the HR1 portion of gp41 into a 22-residue chemotactic peptide MAT-1 (show MAT1A Proteins), the sequence of which is highly conserved across HIV-1 clades.

  10. Dysregulated pericellular proteolysis as a result of unregulated matriptase expression with limited HAI-1 (show SPINT1 Proteins) may contribute to the pathological characteristics of several human B-cell lymphomas.

Mouse (Murine) Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) interaction partners

  1. The proliferation impairment in matriptase-deficient breast cancer cells is caused by their inability to initiate activation of the c-Met signalling pathway in response to fibroblast-secreted pro-HGF (show HGF Proteins).

  2. Matriptase is a critical promoter of late stages of squamous cell carcinoma progression and induces pro-tumorigenic chemokine (show CCL1 Proteins) and cytokine release, and inflammatory cell accumulation in established tumors.

  3. Data show that proteinase-activated receptor (PAR)-2-dependent inflammatory signaling as an essential component of matriptase-mediated and potentiation of ras-mediated oncogenesis.

  4. HAI-1 (show SPINT1 Proteins) regulates the activity of activated matriptase, whereas HAI-2 (show SPINT2 Proteins) has an essential role in regulating prostasin (show PRSS8 Proteins)-dependent matriptase zymogen activation.

  5. Our results reveal unexpected complementary roles of matriptase-prostasin (show PRSS8 Proteins)- and PAR-2 (show F2RL1 Proteins)-dependent proteolytic signaling in the establishment of placental epithelial barrier function and overall embryonic survival.

  6. These findings suggest that TGF-beta (show TGFB1 Proteins) induces epithin/PRSS14 shedding by mediating translocation of epithin/PRSS14 sheddase, TACE (show ADAM17 Proteins), to the membrane.

  7. Matriptase deletion initiates a Sjogren's syndrome-like disease in mice.

  8. Matriptase is required for the active form of hepatocyte growth factor (show HGF Proteins) induced Met, focal adhesion kinase and protein kinase B (show AKT1 Proteins) activation on neural stem/progenitor cell motility.

  9. ST14 expression is downregulated in colitis.

  10. St14 is a critical tumor-suppressor gene in the mouse gastrointestinal tract and adds matriptase to the expanding list of pericellular proteases with tumor-suppressive functions

Suppression of Tumorigenicity 14 (Colon Carcinoma) (ST14) Protein Profile

Protein Summary

The protein encoded by this gene is an epithelial-derived, integral membrane serine protease. This protease forms a complex with the Kunitz-type serine protease inhibitor, HAI-1, and is found to be activated by sphingosine 1-phosphate. This protease has been shown to cleave and activate hepatocyte growth factor/scattering factor, and urokinase plasminogen activator, which suggest the function of this protease as an epithelial membrane activator for other proteases and latent growth factors. The expression of this protease has been associated with breast, colon, prostate, and ovarian tumors, which implicates its role in cancer invasion, and metastasis.

Gene names and symbols associated with ST14

  • ST14 (LOC100101609)
  • suppression of tumorigenicity 14 (colon carcinoma) (ST14)
  • suppression of tumorigenicity 14 (colon carcinoma) (st14-a)
  • suppression of tumorigenicity 14 (colon carcinoma) (St14)
  • Epithin protein
  • hai protein
  • matriptase protein
  • mCAP3 protein
  • mt-sp1 protein
  • mtsp1 protein
  • Prss14 protein
  • snc19 protein
  • st14 protein
  • st14a protein
  • tadg15 protein
  • tmprss1 protein
  • Tmprss14 protein
  • XMT-SP1 protein

Protein level used designations for ST14

membrane-type serine protease 1 , prostamin , serine protease 14 , serine protease TADG-15 , suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin) , suppressor of tumorigenicity 14 protein , tumor associated differentially expressed gene 15 protein , tumor-associated differentially-expressed gene 15 protein , matriptase a , suppression of tumorigenicity 14 (colon carcinoma) a , suppressor of tumorigenicity 14 protein homolog , suppressor of tumorigenicity protein 14 , matriptase/MT-SP1 , protease, serine, 14 (epithin) , matriptase , membrane-type serine protease

GENE ID SPECIES
100101609 Oryctolagus cuniculus
6768 Homo sapiens
394363 Xenopus laevis
767617 Bos taurus
19143 Mus musculus
114093 Rattus norvegicus
Selected quality suppliers for Suppression of Tumorigenicity 14 (Colon Carcinoma) Proteins (ST14)
Did you look for something else?